Header Image

Optimizing stimulation protocols: lower aneuploidy and higher pregnancy rates with r-FSH/r-LH

(Carrión T et al. Human Reproduction. 40(1), 2025)

Design

Retrospective paired cohort study

This study shows:

Read the full article here

Unlocking better outcomes: comparing rFSh+rLH(2:1) vs. rFSH for blastocyst formation and clinical pregnancy in older women with low ovarian reserve in IVF/ICSI

(Kadam K et al. Human Reproduction. 40(1), 2025)

Design

Randomized comparative single-center IVF/ICSI study

This study demonstrated:

Read the full article here

Impact of stimulation with luteinizing hormone activity on IVF outcomes in patients with polycystic ovary syndrome

(Kugelman N et al. J Turk Ger Gynecol Assoc. 13;25(2):60-65. 2024)

Design

Retrospective single-center cohort of PCOS women on GnRH antagonist freeze-all IVF

This study shows:

Read the full article here

A direct healthcare cost analysis of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH‑antagonist protocol

(Chang JC. Arch Gynecol Obstet. 309(2):699-706. 2024)

Design

Direct healthcare cost analysis using 425 IVF/ICSI cycles in a GnRH-antagonist protocol (Taiwan)

This study highlights:

Read the full article here

The role of luteinizing hormone in the management of female infertility: A French Delphi consensus

(Cédrin-Durnerin I et al. J Assist Reprod Genet. 42(12):4361-4373. 2025)

Design

A conventional Delphi-based consensus

This study highlights:

Read the full article here

Read the full article here

Hypo-responsiveness to gonadotropins

two main patient categories with sub-categories